Metoprolol tartrate and succinate: from chemical structure to clinical effectiveness differences

Metoprolol tartrate and succinate: from chemical structure to clinical effectiveness differences

.

Saved in:

Bibliographic Details
Main Authors:	Yu. B. Belousov, M. V. Leonova, O. A. Maneshina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2007-06-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2158
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: M. V. Soura
Published: (2016-01-01)

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: J. V. Lukina, et al.
Published: (2015-12-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

COMPARISON BETAXOLOL AND METOPROLOL TARTRATE THERAPIES IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH STABLE ANGINA
by: A. A. Anderzhanova, et al.
Published: (2016-01-01)

EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS
by: O. L. Barbarash, et al.
Published: (2016-01-01)

TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY
by: V. E. Oleinikov, et al.
Published: (2015-12-01)

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY
by: V. G. Tregubov, et al.
Published: (2016-01-01)

Status and function of betaDadrenoreceptors and their modification during betaDblocker treatment in patients with arterial hypertension and chronic heart failure
by: O. A. Maneshina, et al.
Published: (2005-10-01)

EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS
by: V. E. Oleynikov, et al.
Published: (2016-01-01)

WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL?
by: E. V. Kuleshova
Published: (2016-01-01)

EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS
by: A. L. Hohlov, et al.
Published: (2015-12-01)

EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE
by: S. A. Smakotina, et al.
Published: (2016-01-01)

Antiischemic effects of metoprolol and the risk of carbohydrate metabolism disturbances in angina patients
by: E. V. Bochkareva, et al.
Published: (2012-12-01)

Metabolic Effects of a Succinic Acid<Based Substrate Antihypoxant
by: B. N. Shakh, et al.
Published: (2014-06-01)

ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY
by: V. A. Nevzorova, et al.
Published: (2016-01-01)

EFFECTS OF AMLODIPIN AND METOPROLOL ON AUTONOMIC SYSTEM IN EMOTIONAL AND COLD TESTS IN HYPERTENSIVE PATIENTS WITH DIFFERENT PSYCHOLOGICAL PROFILE
by: M. P. Rubanova, et al.
Published: (2016-01-01)

Evaluation of the zinc succinate toxic eﬀect on the cerebral cortex of rat
by: G. A. Piavchenko, et al.
Published: (2019-06-01)

Ivabradine – a new agent for coronary heart disease treatment
by: O. A. Maneshina, et al.
Published: (2006-06-01)

New approach to heart rate control as mortality reduction method in cardiac patients: potential of a new If inhibitor, ivabradine
by: Yu. B. Belousov, et al.
Published: (2007-12-01)

Synthesis and characterization of novel poly(butylene succinate-co-2-methyl-1,3-propylene succinate)s
Published: (2011-04-01)

Succinate modulates oral dysbiosis and inflammation through a succinate receptor 1 dependent mechanism in aged mice
by: Fangxi Xu, et al.
Published: (2025-06-01)

Synthesis, Growth, and Characterization of Structural, Optical, and Nonlinear Optical Properties of L-Proline Tartrate Added by Lanthanum Chloride Single Crystal
by: Dessale Alemu, et al.
Published: (2024-01-01)

EXPERIMENTAL STUDY OF GASTROPROTECTIVE ACTIVITY OF TRANSDERMAL ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE
by: S. O. Losenkova, et al.
Published: (2015-09-01)

EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE
by: T. N. Khaybullin, et al.
Published: (2015-12-01)

EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS
by: A. R. Kiselev, et al.
Published: (2016-01-01)

Successful treatment of polymedicamentous poisoning with metoprolol, diltiazem and cilazapril
by: Radovanović Milan R., et al.
Published: (2009-01-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

Metoprolol retard effectiveness in patients with arterial hypertension and disturbed circadian blood pressure rhythm
by: P. P. Tikhonov, et al.
Published: (2006-08-01)

The effectiveness of succinate cardioprotection during vascular surgery in high cardiac risk patients
by: I. A. Kozlov, et al.
Published: (2024-02-01)

Effect of the Anionic Surfactant Sodium Starch Octenyl Succinate on the Catalytic Behavior of Lipase
by: FU Weiwei, TENG Chao, ZHOU Mingchun, ZHOU Yadi, QIU Xueyu, SUN Qijie
Published: (2025-06-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

CHANGING SYTOLIC AND DIASTOLIC LV FUNCTION IN CHRONIC HEART FAILURE UNDER THE INFLUENCE OF METOPROLOL
by: T. S. Jahangirov, et al.
Published: (2001-10-01)

Tribo-Electrochemical Characterization of Brush-Scrubbed Post-CMP Cleaning: Results for Tartrate-Supported Removal of Residual Oxides from Copper Films
by: Collin M. Reff, et al.
Published: (2025-07-01)

Brimonidine tartrate 0.15% drops to reduce low post-LASIK residual myopia: A retrospective study
by: Nir Gomel, et al.
Published: (2025-01-01)

The Effect of Ethylmethylhydroxypyridine Succinate on the Dynamics of Cerebral Blood Flow Patterns in Patients with Acute Concomitant Traumatic Brain Injury
by: E. A. Abramova, et al.
Published: (2017-06-01)

SYNERGIC EFFECT OF PREPARATION WITH COORDINATION COMPLEX “TRIMETHYDRAZINIUM PROPIONATE+ETHYMTH METHYLHYDROXYPIRIDINE SUCCINATE” ON ENERGY METABOLISM AND CELL RESPIRATION
by: M. V. Zhuravleva, et al.
Published: (2022-10-01)

EVIDENCE BASE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USE IN PATIENTS WITH STROKE AND ITS CONSEQUENCES
by: A. D. Ehrlikh, et al.
Published: (2015-09-01)

The influence of succinate-containing drugs on physical performance and recovery after exercise
by: S. V. Radko, et al.
Published: (2019-01-01)

METABOLIC EFFECTS OF VARIOUS ANTIHYPERTENSIVE DRUG COMBINATIONS
by: E. E. Alimova, et al.
Published: (2012-12-01)